These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 3216495)
1. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma]. Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495 [No Abstract] [Full Text] [Related]
2. [Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens]. Yamazaki H; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Nakamura T; Ueno K; Ito Y; Imajo K; Mukaiyama T Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1404-11. PubMed ID: 3825458 [No Abstract] [Full Text] [Related]
3. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma]. Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532 [No Abstract] [Full Text] [Related]
4. [Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen]. Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T; Saito Y Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1176-84. PubMed ID: 3430011 [No Abstract] [Full Text] [Related]
5. CHOP versus intensive regimens in non-Hodgkin's lymphoma. Longo DL; DeVita VT; Young RC N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747 [No Abstract] [Full Text] [Related]
6. [A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV]. Yoshida T; Nakamura S; Ohtake S; Itoh K; Kobayashi K; Hirai J; Kanno M; Matsuda T; Naito K; Nakamura E Rinsho Ketsueki; 1988 Sep; 29(9):1383-7. PubMed ID: 3216509 [No Abstract] [Full Text] [Related]
8. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814 [TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma. Cuthbert RJ; Craig JI; Ludlam CA Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956 [No Abstract] [Full Text] [Related]
10. [THP-adriamycin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma]. Ishige K; Matsue K; Tsukuda K; Sakai C; Takagi T Gan To Kagaku Ryoho; 1992 Oct; 19(12):2037-40. PubMed ID: 1417012 [TBL] [Abstract][Full Text] [Related]
11. A clinical phase II study of ProMACE-CytaBOM. Dahlberg S; Miller TP; Fisher RI J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958 [No Abstract] [Full Text] [Related]
12. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma]. Shimamoto Y; Imai S; Endo N Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367 [No Abstract] [Full Text] [Related]
13. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease]. Kumagai K; Takagi T; Sakai C; Wakatsuki S Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506 [No Abstract] [Full Text] [Related]
14. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment]. Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816 [No Abstract] [Full Text] [Related]
15. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype. Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583 [TBL] [Abstract][Full Text] [Related]
16. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients. Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577 [TBL] [Abstract][Full Text] [Related]
18. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study. Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323 [TBL] [Abstract][Full Text] [Related]
19. [The use of novantrone in combination with other preparations in hematosarcoma patients]. Kruglova GV; Demina EA; Evtushenko VV Ter Arkh; 1992; 64(7):40-3. PubMed ID: 1440366 [No Abstract] [Full Text] [Related]